pharma · Hepatitis B, Chronic · Cancer
EmeraMed
Immunocore Ireland Limited
Immunocore Ireland is a pharma organization headquartered in GB. Primary therapeutic focus areas include Hepatitis B, Chronic, Cancer, Chronic HIV infection, Advanced PRAME Positive Cancers, Previously untreated advanced
Ranelagh, IE HQ
2007 Founded
7 Employees
EMA registrant Type
Company details
- Status
- Public
- HQ
- Ranelagh, IE
- Founded
- 2007
- Employees
- 7
- Programs
- 5
- Drugs
- 9
- Patents
- 0
IMCgp100-202
Phase 2 · small molecule · Previously untreated advanced uveal melanoma (UM)
IMCgp100-202 for Previously untreated advanced uveal melanoma (UM) is a Phase 2 program (small_molecule) at Immunocore Ireland Limited with 1 ClinicalTrials.gov record(s).
Internal code IMCgp100-202
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Immunocore Ireland Limited
- Phase
- Phase 2
- Modality
- small_molecule
- Indication
- Previously untreated advanced uveal melanoma (UM)
- Status
- active
- Trials
- 1